Tweet id,Created Time,Tweet Details,Retweet counts,Source URL
911010812881387520,2017-09-21 23:34:38,"RT @malcmccoll: Looking forward to new @Viralytics #CAVATAK preclinical &amp; clinical data @SITC2017. Podium &amp; poster details: 
https://t.co/E…",3,http://twitter.com
904518050975596544,2017-09-04 01:34:43,Comments on CAVATAK clinical data from Dr Andtbacka - Novel Combinations for Metastatic Melanoma https://t.co/8FK0yfDU0u via @onclive,3,http://twitter.com
892167087199666176,2017-07-31 23:36:23,"BIO2017 - Dealmaker's Intentions: Surprise, Oncology is the Focus https://t.co/Oa4qLAE6RU https://t.co/QD5cOc2wAr",2,http://twitter.com
892165066677600256,2017-07-31 23:28:22,Cancer cure not to be sneezed at https://t.co/U5dF9NCISM,7,http://twitter.com
884619679561637888,2017-07-11 03:45:41,Top broker names 3 healthcare shares to buy  https://t.co/DRKZSBIp5v #investing #motleyfool,0,http://twitter.com
879855635701014528,2017-06-28 00:15:05,@Viralytics Newsletter out today. https://t.co/8ESQMSt7jm https://t.co/RRluOBxFgo,2,http://twitter.com
879846655943614464,2017-06-27 23:39:24,Behind big pharma's race to develop the next wave of cancer therapy https://t.co/qahV1Ce1Xl via @telebusiness,0,http://twitter.com
871862674291793920,2017-06-05 22:53:54,RT @KeithDredge: Congrats to @Viralytics on promising data #ASCO17 https://t.co/8LZX8kSfrP,4,http://twitter.com/download/iphone
871862467411927040,2017-06-05 22:53:05,RT @malcmccoll: @Viralytics #CAVATAK MITCI podium presentation #ASCO17 https://t.co/EqNBvCSpIt,3,http://twitter.com/download/iphone
871855875446550528,2017-06-05 22:26:53,RT @malcmccoll: @Viralytics #CAVATAK @Merck collaboration in KEYNOTE 200 #ASCO17 https://t.co/6Ul2EdCwl0,1,http://twitter.com/download/iphone
871854729466232833,2017-06-05 22:22:20,RT @malcmccoll: Big crowd and strong interest in @Viralytics #CAVATAK MITCI trial #ASCO17 https://t.co/d0YxHZnEWu,3,http://twitter.com/download/iphone
855318649317412864,2017-04-21 07:13:51,RT @malcmccoll: Look forward to 2 @Viralytics #CAVATAK posters #ASCO17 on MITCI and KEYNOTE 200.  More here: https://t.co/Eoc4vuRtoh,3,http://twitter.com
854921179005460481,2017-04-20 04:54:27,RT @InvestingStockz: Viralytics: Cavatak/Yervoy Combo Enters The Spotlight - https://t.co/RNHiFkbTeG,1,http://twitter.com
851663943651086336,2017-04-11 05:11:21,Bioshares' coverage of CAVATAK data at last week's AACR Meeting available here https://t.co/JOw7MVDEV8,2,http://twitter.com
849798563479433216,2017-04-06 01:39:00,Combined immunotherapy shows early promise in advanced melanoma https://t.co/VRZKIwHatH,0,http://twitter.com
849793287229554688,2017-04-06 01:18:02,"RT @JacobPlieth: Cavatak (Viralytics oncolytic virus) + Yervoy in melanoma, via Brendan Curti #AACR17 $VLA $ONCY $AMGN https://t.co/uBlbKQv…",10,http://twitter.com
849792469235453952,2017-04-06 01:14:47,Common Cold Virus Improves Response with Immunotherapy in Advanced Melanoma https://t.co/o3J9R66gOj,1,http://twitter.com
849400014212399104,2017-04-04 23:15:19,"RT @MedicalAbacus: Cavatak (Coxsackievirus 22, CVA21) + Yervoy (ipilimumab) in melanoma
#AACR17 #AACR2017 #Melanoma #CancerMoonshot #cancer…",5,http://twitter.com
849397934710018049,2017-04-04 23:07:03,AACR Press Release on MITCI Trial https://t.co/D03PS2YGkN https://t.co/lUgfkZLDnK,0,http://twitter.com
849369835209469952,2017-04-04 21:15:23,Combined immunotherapy shows early promise in advanced melanoma https://t.co/VRZKIwpzC9,1,http://twitter.com
849369745816211459,2017-04-04 21:15:02,Small biotech — big ambitions. Viralytics’ oncolytics therapy makes the showcase round at #AACR17 with pos ... - https://t.co/is1WYlyV2G,0,http://twitter.com
849355290998960128,2017-04-04 20:17:36,RT @malcmccoll: Full house for Dr Charles Rudin @Viralytics #CAVATAK plenary on KEYNOTE 200 #AACR17 https://t.co/YtyOhypAPM,2,http://twitter.com/download/iphone
849355251165650944,2017-04-04 20:17:26,RT @malcmccoll: @Viralytics #CAVATAK plenary session MITCI trial- standing room only https://t.co/iYpLmFQySv,4,http://twitter.com/download/iphone
849355225718812672,2017-04-04 20:17:20,RT @malcmccoll: Dr Brendan Curti #AACR2017 Press Conference on @Viralytics #CAVATAK MITCI trial! https://t.co/g9l600Jtkr,2,http://twitter.com/download/iphone
849068640230150144,2017-04-04 01:18:33,RT @malcmccoll: Great interest in @Viralytics #CAVATAK CAPRA poster @AACR2017 Find it here:https://t.co/RWK2qCSua6 https://t.co/3rs1FWSCy1,2,http://twitter.com
849061312692969473,2017-04-04 00:49:26,RT @malcmccoll: Delighted with promising initial results from @Viralytics #CAVATAK and pembro study in melanoma pts #AACR2017 https://t.co/…,3,http://twitter.com
847974113259868160,2017-04-01 00:49:17,"RT @JacobPlieth: Attending #AACR17 ? Read my 2 preview stories, with hyperlinks to key abstracts: https://t.co/R1vefeCPL0 $LLY $VLA https:/…",21,http://twitter.com/download/iphone
847298088095989760,2017-03-30 04:03:00,"RT @malcmccoll: Look forward to @Viralytics #CAVATAK at #AACR17 incl webcast of latest MITCI data. More here:
https://t.co/4wr8jX2HID",3,http://twitter.com/download/iphone
838663400334872577,2017-03-06 08:11:50,RT @malcmccoll: Looking forward to strong @Viralytics presence #AACR17.    https://t.co/KMV8f56cY4,3,http://twitter.com/download/iphone
838663379602415616,2017-03-06 08:11:45,RT @malcmccoll: Looking forward to #AACR17 with 2 podiums and 1 poster on @Viralytics #CAVATAK checkpoint combo trials. https://t.co/fwiC8o…,2,http://twitter.com/download/iphone
826608696843128832,2017-02-01 01:50:45,"New Analyst Report from @ROTHCapital 'A Dash of Virus Completes the
Immunotherapy Cocktail' https://t.co/9mCVD6Uik6",0,http://twitter.com
823289616232919040,2017-01-22 22:01:55,RT @BernardAFox: Dr Brendan Curti @curti2316 med onc guru @ChilesResearch @ProvHealth talks options for @AIMatMelanoma patients who progres…,6,http://twitter.com
811336336825167872,2016-12-20 22:23:51,4 under-the-radar shares I’m tipping to shine in 2017 | Motley Fool Australia https://t.co/BObfgmPQxs,0,http://twitter.com
806048288625414144,2016-12-06 08:11:02,RT @biotech_daily: JCP Takes 5% Of @Viralytics - subscribe to Biotech Daily https://t.co/4E9331THtC,1,http://twitter.com/download/iphone
802762080042373120,2016-11-27 06:32:49,"RT @malcmccoll: @Viralytics #CAVATAK one of the highlights of state of the art  investigational immunotherapies #SITC2016!
https://t.co/nby…",4,http://twitter.com/download/iphone
801335559977398272,2016-11-23 08:04:20,RT @malcmccoll: Delighted to announce formation of @Viralytics Clinical Advisory Board with global thought leaders. Details here: https://t…,1,http://twitter.com/download/iphone
801329362754793474,2016-11-23 07:39:42,"RT @malcmccoll: AGM deck with latest @Viralytics #CAVATAK results and forward projections is here:
https://t.co/EiIJWyh5w9",2,http://twitter.com/download/iphone
800838575319175168,2016-11-21 23:09:29,Viralytics' anticancer virus aces checkpoint inhibitor combo trials https://t.co/AW16fUWI0Q,5,http://twitter.com
800838479814922240,2016-11-21 23:09:07,RT @EdisonHealth: Viralytics presents new and updated data at #SITC2016. Updated valuation of A$1.6/share and our take: https://t.co/MS7QWQ…,5,http://twitter.com
798275328783183874,2016-11-14 21:24:04,"RT @JPZaragoza1: Small set of patients and early, but @Viralytics combo data presented at #SITC2016 look good https://t.co/nqB60Vgsjn $VLA…",2,http://twitter.com/download/iphone
797897183945076737,2016-11-13 20:21:27,RT @malcmccoll: Dr Ann Silk @RutgersCancer presenting @Viralytics #CAVATAK #melanoma CAPRA study poster #sitc2016. Posted:  https://t.co/qb…,2,http://twitter.com/download/iphone
797549226074877952,2016-11-12 21:18:47,RT @malcmccoll: Impressive results in @Viralytics #CAVATAK CANON poster #SITC2016 https://t.co/6oaonV6M6S,2,http://twitter.com/download/iphone
797549205145300992,2016-11-12 21:18:42,RT @malcmccoll: Excellent #Viralytics #CAVATAK presentation by Dr Annels on CANON study #SITC2016 https://t.co/CuQb29OKkU,3,http://twitter.com/download/iphone
788239013991686144,2016-10-18 04:43:20,RT @malcmccoll: Looking forward to #SITC16 with 5 posters @Viralytics #CAVATAK! https://t.co/Obo96AS54n,1,http://twitter.com/download/iphone
786323678535438336,2016-10-12 21:52:28,2 biotech shares with explosive potential | Motley Fool Australia https://t.co/URTYckcSF9,1,http://twitter.com
785768022157828096,2016-10-11 09:04:30,RT @malcmccoll: Full house for @Viralytics #CAVATAK CANON poster discussion session #ESMO16 https://t.co/YDhEeGQdXf,3,http://twitter.com/download/iphone
785628646157406208,2016-10-10 23:50:40,Viralytics CAVATAK YERVOY Combination Demonstrates Promising Clinical Response Rates In Advanced Melanoma https://t.co/5lM4gYVpOW,2,http://twitter.com
785405877054353408,2016-10-10 09:05:27,RT @malcmccoll: @Viralytics at poster discussion session #ESMO16 https://t.co/xpjtHA1Lew,3,http://twitter.com/download/iphone
785405804727840768,2016-10-10 09:05:10,RT @malcmccoll: Full house at Poster Discussion Session @ESMO16. 2 @Viralytics posters discussed. https://t.co/q55BGrmzOr,3,http://twitter.com/download/iphone
784867461749284864,2016-10-08 21:25:59,"RT @malcmccoll: Great potential for @Viralytics #CAVATAK in superficial bladder cancer reported #ESMO16. CANON results here:
https://t.co/n…",3,http://twitter.com
784718622027427840,2016-10-08 11:34:33,RT @malcmccoll: Very promising @Viralytics results in MITCI study at #ESMO16 in advanced melanoma patients. Poster here: https://t.co/BeFAK…,3,http://twitter.com
784718545372352513,2016-10-08 11:34:15,RT @malcmccoll: Big audience for opening session on cancer immunotherapy at ESMO. https://t.co/p9q1ZYvFnJ,2,http://twitter.com
783477444846112769,2016-10-05 01:22:33,RT @malcmccoll: Impressive @Viralytics #CAVATAK CANON data at Onc Virus Conf presented by Prof Pandha. Deck here: https://t.co/shoiE0NbVI h…,2,http://twitter.com
783442477017542656,2016-10-04 23:03:36,RT @malcmccoll: Excellent presentation @Viralytics #CAVATAK at Onc Virus Conference. Deck is here: https://t.co/cJ9iIkHhAZ https://t.co/xv4…,3,http://twitter.com
758490870945427456,2016-07-28 02:34:50,VLA MD/CEO Malcolm McColl interviewed by @CommSec's @TomPetrovski as part of the CommSec Exec. Series; watch it at https://t.co/7Lrs5y8aeN,2,http://twitter.com
745071836409401344,2016-06-21 01:52:23,RT @ChilesResearch: .@ChilesResearch is proud to join @CancerResearch in celebrating #WhiteOutCancer Day! Together we can #FinishCancer. ht…,19,http://twitter.com
740066552486100992,2016-06-07 06:23:10,RT @malcmccoll: Delighted with @Viralytics #ASCO16 with CAVATAK tumour targeting in STORM and checkpoint up regulation in CALM. https://t.c…,4,http://twitter.com
739603311498649600,2016-06-05 23:42:25,Extended interview with Dr Malcolm McColl https://t.co/YquiuMXCBS via @ABCNews,1,http://twitter.com
739602070165061632,2016-06-05 23:37:29,RT @malcmccoll: Positive CALM results @Viralytics #CAVATAK #ASCO16 @RobertAndtbacka https://t.co/KABW2POfbn,6,http://twitter.com
739286670256668672,2016-06-05 02:44:12,"RT @ElysseMorgan: Making cancers disappear w @Viralytics, turning food waste into profit + @JuliaLeeAU. The Business 15m on @ABCNews24 http…",5,http://twitter.com
733162210160082944,2016-05-19 05:07:47,RT @malcmccoll: @Viralytics #CAVATAK #ASCO16 abstracts now on line here:https://t.co/6rQJxgqoix. Will be a v busy ASCO!,2,http://twitter.com
733086795294904320,2016-05-19 00:08:06,"RT @malcmccoll: Latest EDISON research on @Viralytics is here:
 https://t.co/WTkCRTBNAM",3,http://twitter.com
733086583503491073,2016-05-19 00:07:16,"RT @malcmccoll: Look forward to 2 @Viralytics posters at #ASCO16. Details are here: 
https://t.co/6rQJxgqoix",3,http://twitter.com
722573240669835265,2016-04-19 23:50:59,RT @ChilesResearch: Dr Brendan Curti is lead author on #AACR16 abstract showing intralesional CVA21 + ipi is promising combo in melanoma ht…,8,http://twitter.com
722304667649093632,2016-04-19 06:03:47,Viralytics reports data from three studies https://t.co/sIQj8PJDJl via @@ShareThis,0,http://twitter.com
722304465781391360,2016-04-19 06:02:59,"RT @malcmccoll: V promising initial results combo @Viralytics #CAVATAK with Yervoy in #melanoma patients #AACR 
https://t.co/NUzsxyL7Ad",2,http://twitter.com
721902236385681412,2016-04-18 03:24:40,"RT @malcmccoll: 3 posters on @Viralytics at #AACR16 tomorrow espec promising early data #CAVATAK YERVOY combo in #melanoma patients 
https:…",2,http://twitter.com
709536853465047040,2016-03-15 00:29:03,#ASX announcement: Positive CAVATAK Clinical Data Presented at 2016 European Assoc. of Urology Congress. Read it at https://t.co/5ICjo4SSWW,3,http://twitter.com
709516096227844096,2016-03-14 23:06:34,RT @sweetaslou: CAVATAK: novel oncolytic virus for example of NIMBC #eau16 https://t.co/gySzOjgbkh,2,http://twitter.com
702621297616879617,2016-02-24 22:29:06,RT @malcmccoll: $VLA @Viralytics half year report with strong cash position and @CAVATAK advancing in 5 clinical trials https://t.co/CJ76tB…,1,http://twitter.com
678804454506819585,2015-12-21 05:09:28,"RT @malcmccoll: BioShares list @Viralytics $VLA as one of top 6 picks for 2016. One of best performers in their portfolio in 2015 
https://…",1,http://twitter.com
676549546759991297,2015-12-14 23:49:16,Viralytics Ltd Completes 28 Million Placement SPP To Follow https://t.co/Days8jevlv,0,http://twitter.com
676543845241229313,2015-12-14 23:26:36,RT @medifydaily: $VLA/@Viralytics: Raises &gt;$30m in placement run by @Bell_Potter Securities and Roth Capital Partners. @Orbimed set to emer…,1,http://twitter.com
676543755730554880,2015-12-14 23:26:15,"RT @malcmccoll: @Viralytics $VLA pleased to announce $28M placement and welcome @OrbiMed as new investor. Details here: 
https://t.co/sgLfk…",1,http://twitter.com
667505095995555841,2015-11-20 00:49:51,RT @BernardAFox: Dr Andtbacka @SocietyMelanoma talk oncolytic viral therapy/delighted @ProvHealth @ChilesResearch helped @Viralytics https:…,6,http://twitter.com
666846627387211776,2015-11-18 05:13:20,"#Viralytics #AGM was held today in #Sydney, NSW. Find the AGM presentation here: https://t.co/qwrSdsQGCZ https://t.co/tyhscDxTUV",1,http://twitter.com
664567647661494273,2015-11-11 22:17:28,"Broker Watch: Ridley Corp, Aurizon, Viralytics, PS&amp;C https://t.co/CdyT8PHOEu via @FinancialReview",1,http://twitter.com
663903804237045761,2015-11-10 02:19:36,RT @ChilesResearch: Congrats to @sitcancer 2015 Visionary/Legacy Awardee @BernardAFox! Proud to have you on our #FinishCancer Team. https:/…,12,http://twitter.com
663900266769485824,2015-11-10 02:05:32,"RT @malcmccoll: Delighted with 4 great @Viralytics #CAVATAK posters at #SITC2015 in multiple indications. 
Details here:   https://t.co/ulq…",1,http://twitter.com
663899036122910721,2015-11-10 02:00:39,Viralytics: updated data boosts interest in cancer drug https://t.co/MUzcMYdAxo,3,http://twitter.com
663520787287031808,2015-11-09 00:57:37,Positive data from clinical studies of lead drug candidate CAVATAK™ presented at 30th Annual Meeting of the SITC. https://t.co/8YyHUQKJTI,1,http://twitter.com
663476176065683456,2015-11-08 22:00:21,RT @malcmccoll: Excellent results @Viralytics  #CAVATAK #SITC2015 with @RobertAndtbacka https://t.co/REtpewuuLv,3,http://twitter.com
663476148471394305,2015-11-08 22:00:15,RT @malcmccoll: Positive CANON data @Viralytics  #CAVATAK #SITC2015 with Prof Pandha https://t.co/Kgh1jFh8e8,5,http://twitter.com
662439462496960512,2015-11-06 01:20:50,Viralytics and @Merck Collaborate in Lung and Bladder Cancer. Full release: https://t.co/A01SoYxXbD,5,http://twitter.com
637042441028177920,2015-08-27 23:22:08,RT @malcmccoll: The latest research report from ROTH Capital Partners on #Viralytics $VLA can be found here: http://t.co/nuBQgnaQss,2,http://twitter.com
633055915747373056,2015-08-16 23:21:06,RT @BernardAFox: Dr Brendan Curti #immunotherapy working to improve outcomes/many tx options @ChilesResearch @ProvHealth @Viralytics http:/…,5,http://twitter.com
633055665812967424,2015-08-16 23:20:06,RT @DrGeorgeSMack: I spoke with analyst John Hester of Bell Potter in Australia. Comparing Viralytics' Cavatak to Amgen's T-VEC. http://t.c…,3,http://twitter.com
633055570761658369,2015-08-16 23:19:44,RT @malcmccoll: The latest Edison report with summary of #Viralytics #CAVATAK   clinical program is here http://t.co/c6ErTEUEE0,1,http://twitter.com
622591051740483584,2015-07-19 02:17:28,RT @malcmccoll: A pleasure presenting an update on #Viralytics #CAVATAK at the excellent #BioShares2015 summit. The deck is here: http://t.…,4,http://twitter.com
615723396106579968,2015-06-30 03:27:51,"RT @malcmccoll: A pleasure appearing on ABC TV The Business to provide an update on #Viralytics #CAVATAK 
http://t.co/tGTrph7Y6g",3,http://twitter.com
610991615109234688,2015-06-17 02:05:27,RT @malcmccoll: Prof Hardev Pandha presenting promising early #Viralytics #CAVATAK STORM trial data at #OVCBoston2015 http://t.co/zK0odnUJJ3,2,http://twitter.com
610973884830121984,2015-06-17 00:55:00,Viralytics presents results from Phase 2 CALM biopsy extension study and Phase 1/2 STORM trial at OVC Boston 2015 http://t.co/ugSV6fIfJZ,2,http://twitter.com
610661061323157504,2015-06-16 04:11:57,VLA presents promising CAVATAK results from 2 trials at International Conference on Oncolytic Virus Therapeutics http://t.co/S9V04laF7d,0,http://twitter.com
610633267969011712,2015-06-16 02:21:30,RT @malcmccoll: Dr Shafren presenting #Viralytics #CAVATAK to full house @OVCBoston2015 this evening http://t.co/dLPpgBqtHx,4,http://twitter.com
610259707047997442,2015-06-15 01:37:06,@RobertAndtbacka to discuss #CAVATAK CALM Melanoma Final Results on Conf Call 16 July US time. https://t.co/I6AzhP59CN,0,http://twitter.com
609142474120892416,2015-06-11 23:37:37,@Viralytics #CAVATAK mentioned in a Clinical Panel on Emerging Therapies for Malignant Melanoma https://t.co/3FP9QfZovp via @YouTube,1,http://twitter.com
608473935244500992,2015-06-10 03:21:05,"RT @malcmccoll: Post ASCO update on #Viralytics by Bioshares can be found here: 
http://t.co/I4O31upmvy",1,http://twitter.com
608473821281017856,2015-06-10 03:20:38,RT @malcmccoll: Looking forward to Oncolytic Virus conf in Boston with #Viralytics #CAVATAK in 3 podium and 2 poster presentations:http://t…,3,http://twitter.com
608145129296175104,2015-06-09 05:34:32,Viralytics to present initial positive results of clinical trial of CAVATAK in bladder cancer at OVT Conference http://t.co/qWNxUvF5JG,1,http://twitter.com
605596635339423745,2015-06-02 04:47:43,@RobertAndtbacka at the @Viralytics Phase 2 CALM Melanoma Trial Poster at #ASCO15. https://t.co/6qS9cEH8l1,2,http://twitter.com
605546274469724161,2015-06-02 01:27:36,Positive final results from CAVATAK Phase2 Melanoma trial presented at American Society for Clinical Oncology Meeting http://t.co/zneMyunT4I,1,http://twitter.com
605162505355194369,2015-06-01 00:02:39,RT @arleneweintraub: Will the common cold cure cancer? @Viralytics is presenting data on its virus-based drug at #ASCO2015 http://t.co/NPQp…,2,http://twitter.com
603061544713261056,2015-05-26 04:54:11,Viralytics $VLA has released its May Shareholder Newsletter http://t.co/AArMHREYFH,5,http://twitter.com
597544621774745603,2015-05-10 23:31:54,RT @oeuvrer: Great article on @Viralytics Chief Scientist Darren Shafren in Good Weekend mag http://t.co/KMY3srch5S @RobertAndtbacka @malcm…,4,http://twitter.com
591061532609421313,2015-04-23 02:10:25,@RobertAndtbacka presenting @Viralytics CALM poster trial at #AACR15  https://t.co/Mx9Bqt81V8,0,http://twitter.com
591060404551331840,2015-04-23 02:05:56,@RobertAndtbacka presenting @Viralytics CALM trial poster at #AACR15 https://t.co/Mx9Bqt81V8,0,http://twitter.com
591059984957374464,2015-04-23 02:04:16,The @Viralytics team in front our CALM trial poster at #AACR15 @RobertAndtbacka @malcmccoll  https://t.co/rH2APXAy32,1,http://twitter.com
590393757104640000,2015-04-21 05:56:55,Viralytics update on CALM and STORM Clinical Trials at American Association for Cancer Research Annual Meeting http://t.co/tvbFZOY5Ee,1,http://twitter.com
586315263747887104,2015-04-09 23:50:26,Viralytics featured in The Australian highlighting the trend for US investors finding value in Aus biotech sector http://t.co/cnTTjMIQnw,2,http://twitter.com
575454391462821888,2015-03-11 00:33:13,Viralytics further coverage in Bioshares following Roth Capital report and increased US interest http://t.co/NlN3kf3okR,1,http://twitter.com
572246923907735552,2015-03-02 04:07:53,Roth Capital Partners initiate research coverage of Viralytics - 12 month share price target of A$3.84 - read more at http://t.co/5jSq7sG1ln,1,http://twitter.com
564948667925159936,2015-02-10 00:47:13,Bioshares has published a briefing report on $VLA after recent presentations by MD &amp; CEO Dr Malcolm McColl -- http://t.co/gZt8Bs6Uur,1,http://twitter.com
560643117674528768,2015-01-29 03:38:30,Herald Sun senior business writer John Beveridge provided an update on $VLA after launch of its latest trial -- http://t.co/pu4BSrg7gL #asx,2,http://twitter.com
559884568996483074,2015-01-27 01:24:18,Viralytics $VLA has initiated a Phase 1 clinical trial of CAVATAK™ in patients with superficial bladder cancer -- http://t.co/kshMmQYbhl,2,http://twitter.com
555168751956418561,2015-01-14 01:05:19,"Viralytics $VLA MD &amp; CEO Dr Malcolm McColl was interviewed on Sky @BusinessChannel last week, see the vision here -- http://t.co/YQ85jLUb93",2,http://twitter.com
554503215870267392,2015-01-12 05:00:43,Viralytics $VLA has received new coverage from Edison Investment Research valuing the company at $0.76 per share -- http://t.co/isHkeRcyvs,2,http://twitter.com
547257316492312576,2014-12-23 05:08:06,"Viralytics $VLA has been featured in Bioshares ""Top Six Stock Picks"" for 2015. Read more at http://t.co/VrUSDmSMvz #biotech #asx #ausbiz",2,http://twitter.com
540708186622160897,2014-12-05 03:24:12,Viralytics $VLA to commence clinical trial assessing CAVATAK in combination with Yervoy for late stage melanoma -- http://t.co/8OG9qALmYh,2,http://twitter.com
539572959937961984,2014-12-02 00:13:13,Viralytics $VLA receives $2.5m R&amp;D tax incentive for FY2014 http://t.co/zb2s946uD1 #asx #ausbiz,1,http://twitter.com
537832664556765184,2014-11-27 04:57:54,Viralytics $VLA Managing Director &amp; CEO Dr Malcolm McColl's presentation at today's AGM -- http://t.co/w8USDuPMwy #ausbiz #asx #Biotech,1,http://twitter.com
537829248459751425,2014-11-27 04:44:19,Chairman's address from today's Viralytics $VLA AGM in Sydney -- http://t.co/iL2Ju7TaZT #ausbiz #biotech #asx #immunotherapy,0,http://twitter.com
537396053478084608,2014-11-26 00:02:58,Viralytics $VLA has released its November 2014 shareholder newsletter -- http://t.co/IVqGHf0NQD #ausbiz #biotech #asx,2,http://twitter.com
533074616005050369,2014-11-14 01:51:07,Viralytics $VLA receive UK approval for CAVATAK Phase I clinical trial in patients with superficial bladder cancer -- http://t.co/67ZUKGgJBo,2,http://twitter.com
530615107093417984,2014-11-07 06:57:54,Viralytics $VLA presents data showing improved CAVATAK anti-cancer activity at SITC meeting in Maryland -- http://t.co/gG9QVjkzEY #biotech,2,http://twitter.com
524439646864814080,2014-10-21 05:58:50,Viralytics $VLA has released a new investor presentation for the 5th Annual Australian Microcap Conference -- http://t.co/2xpnhEes7D,1,http://twitter.com
512051412239278080,2014-09-17 01:32:24,Viralytics $VLA will provide two updated CAVATAK poster presentations at ESMO in Madrid -- http://t.co/JXuSUHtevg #biotech #asx #ausbiz,1,http://twitter.com
509124739994906624,2014-09-08 23:42:51,Former CSL executive Peter Turvey and CEO Dr Malcolm McColl have been appointed to the Viralytics' board -- http://t.co/egBN6TQi6A $VLA #asx,1,http://twitter.com
504441677050679296,2014-08-27 01:34:02,Viralytics $VLA has released full year financial results and operational highlights -- http://t.co/l0q8MX6Yho #biotech #asx #ausbiz,1,http://twitter.com
494278331043291136,2014-07-30 00:28:32,"Viralytics $VLA releases new shareholder newsletter discussing trials, recent conference presentations &amp; more -- http://t.co/FBUsd64fVs #asx",1,http://twitter.com
493997215459725314,2014-07-29 05:51:28,Viralytics $VLA receives positive commentary from the investment panel at 10th Bioshares Biotech Summit. Read more: http://t.co/wbVIe1N4Y6,1,http://twitter.com
491758408014364673,2014-07-23 01:35:15,"Viralytics has launched its new website, redesigned for a more accessible and informative experience, please visit at http://t.co/tNmmBVNJDR",2,http://twitter.com
477260794925563905,2014-06-13 01:26:55,Viralytics $VLA featured on Channel 7 News last night -- 'Common cold link to melanoma fight' http://t.co/bIOke2IrHn #melanoma #biotech #asx,3,http://twitter.com
466734852927418368,2014-05-15 00:20:35,An update on the Phase 2 melanoma trial of CAVATAK™ to be presented at ASCO conference commencing 30 May in Chicago http://t.co/2MHvNdU4WO,1,http://twitter.com
454405424813309952,2014-04-10 23:47:50,The audio &amp; slide deck from Dr Andtbacka's CAVATAK™ presentation at AACR is available at http://t.co/dDL6nwSNyF $VLA $VRACY #asx #biotech,1,http://twitter.com
453323726923132928,2014-04-08 00:09:33,Further positive Phase II trial data for CAVATAK™ presented at American Association of Cancer Research Conference -- http://t.co/SjfTR6fFQV,1,http://twitter.com
451166013782892545,2014-04-02 01:15:34,Viralytics has released a new corporate overview video -- https://t.co/mhqZMJmeOy $VLA $VRACY #asx #ausbiz #biotech,1,http://twitter.com
448681768845983744,2014-03-26 04:44:04,Viralytics featured in a story on the new frontiers of Australia's biotech industry on ABC's The Business on Monday - http://t.co/JzOS9fb9bL,2,http://twitter.com
445360118553518080,2014-03-17 00:45:01,Viralytics announces international institutional ownership as part of $27.1m capital raising -- http://t.co/z0QmkYyI9t $VLA $VRACY #ausbiz,1,http://twitter.com
443931701094260736,2014-03-13 02:09:00,Viralytics has completed its $27.1m capital raising -- http://t.co/g1nASsOnQq $VLA $VRACY #asx #ausbiz #biotech #capitalraising,1,http://twitter.com
441739297234776065,2014-03-07 00:57:10,CEO Dr Malcolm McColl to present at two prominent US conferences next week -- http://t.co/tfvEIso4jT $VLA $VRACY #roth #bernstein #biotech,0,http://twitter.com
441360572584435712,2014-03-05 23:52:15,CEO Dr Malcolm McColl's presentation to be delivered at today's general meeting in Sydney -- http://t.co/lmm3am1glE $VLA $VRACY #asx #ausbiz,0,http://twitter.com
441359003977674753,2014-03-05 23:46:01,Interim Phase 2 CALM trial data for CAVATAK to be presented at AACR Conference next month -- http://t.co/vtLJlNDCUy $VLA $VRACY #asx #AACR14,0,http://twitter.com
441356182645522432,2014-03-05 23:34:48,Viralytics has commenced the Phase 1/2 STORM clinical trial in UK cancer patients -- http://t.co/pD6rnOzYF7 $VLA $VRACY #biotech #asx,1,http://twitter.com
439196934977241089,2014-02-28 00:34:43,Viralytics' $4.1 million entitlement offer has closed fully subscribed -- http://t.co/K8EdeS6arc $VLA $VRACY #asx #biotech #ausbiz,0,http://twitter.com
439167833826947072,2014-02-27 22:39:05,An excellent story from James Dunn of @sharecafetweets on recent developments for Viralytics -- http://t.co/4E8vVBngku  $VLA $VRACY,1,http://twitter.com
435636800543932416,2014-02-18 04:48:01,Viralytics has released its February 2014 shareholder newsletter -- http://t.co/iF8uWDNNmY $VLA $VRACY #asx #ausbiz #biotech,1,http://twitter.com
435633338020151297,2014-02-18 04:34:16,RT @BusInsiderAU: 23 Australian Biotech Stocks To Watch This Year - http://t.co/FnjnEH9jfa,2,http://twitter.com
430837054109274113,2014-02-04 22:55:32,"Viralytics $VLA CEO Dr Malcolm McColl was interviewed on Sky @BusinessChannel on Friday, see the vision here -- http://t.co/XDv7LvzF0e",2,http://twitter.com
430489242385412096,2014-02-03 23:53:28,Viralytics $VLA expands US patent coverage -- http://t.co/ayingGrChp #ausbiz #biotech #asx,1,http://twitter.com
429067842684583936,2014-01-31 01:45:20,RT @newcastleherald: Hunter cancer drug research wins $27m: video: An anti-cancer drug developed at the Hunter Medical Research Ins... http…,3,http://twitter.com
429017579055640576,2014-01-30 22:25:36,RT @ThePharmaLetter: 'We can now more rapidly advance the program': Viralytics raises A$27m capital for #melanoma drug http://t.co/trfZhgQs…,2,http://twitter.com
428653419566362624,2014-01-29 22:18:33,Viralytics $VLA undertaking $27.1m transformational capital raising expected to fund the company to the end of 2016 http://t.co/4Af0ZM8W0m,2,http://twitter.com
424034781739753472,2014-01-17 04:25:44,Viralytics $VLA hits enrolment target for US Phase 2 melanoma trial of anti-cancer drug CAVATAK™ -- http://t.co/JS1viQMlhv,0,http://twitter.com
